Consequently, MsA may effectively alleviate cholinergic insufficiency and neurotoxicity associated with Aβ accumulation in AD through the dual suppression of AChE and BChE activity, offering novel insights and methods for treatment. The gene discussed is ACHE; the disease is Alzheimer disease.